research Treatment of Chronic Alopecia Areata With Tildrakizumab: An Open-Label Pilot Study 3 citations, March 2020 in “International Journal of Dermatology” Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.
